Smith & Nephew plc Stock Rating Upgraded by Numis Securities Ltd (SNN)
Shares of Smith & Nephew plc (NYSE:SNN) opened at 80.65 on Friday. Smith & Nephew plc has a 52-week low of $55.22 and a 52-week high of $80.99. The stock has a 50-day moving average of $76.53 and a 200-day moving average of $73.54. The company has a market cap of $14.404 billion and a price-to-earnings ratio of 25.85.
Smith & Nephew plc (NYSE:SNN) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.89 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.93 by $0.04. Analysts expect that Smith & Nephew plc will post $4.14 EPS for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Canaccord Genuity reiterated a “buy” rating on shares of Smith & Nephew plc in a research note on Monday. They now have a $82.00 price target on the stock, up previously from $81.00. Separately, analysts at Berenberg Bank reiterated a “hold” rating on shares of Smith & Nephew plc in a research note on Thursday, May 1st. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Smith & Nephew plc in a research note on Monday, April 28th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have issued a buy rating to the company. Smith & Nephew plc currently has a consensus rating of “Buy” and an average price target of $82.50.
Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (NYSE:SNN) and advanced wound management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.